A Phase 1, Two Period, Double-blind, Randomised, Placebo-controlled, Cross- Over Study Investigating the Safety, Local Tolerability and Systemic Exposure of Cyclosporine A and Placebo (Vehicle) Following Single and Multiple Ocular Doses of CyclASol® and Placebo in Healthy Volunteers (CYS-001).
Phase of Trial: Phase I
Latest Information Update: 09 Sep 2016
At a glance
- Drugs Ciclosporin (Primary)
- Indications Dry eyes
- Focus Adverse reactions
- Sponsors Novaliq
- 23 Sep 2014 Results published in a Novaliq media release.
- 19 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 09 Apr 2014 New trial record